Views 325
Your Token Count0

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research
4 Problem Substances Researched for Cataractogenic
3 Diseases Researched for Cataractogenic

View the Evidence:
3 Abstracts with Cataractogenic Research

Pubmed Data : JAMA Ophthalmol. 2013 Sep 19. Epub 2013 Sep 19. PMID: 24052188
Study Type : Human Study
Additional Links
Problem Substances : Statin Drugs
Adverse Pharmacological Actions : Cataractogenic
Pubmed Data : Ann Univ Mariae Curie Sklodowska Med. 2002 ;57(2):165-71. PMID: 12898835
Study Type : Animal Study
Additional Links
Problem Substances : Atorvastatin, Statin Drugs
Adverse Pharmacological Actions : Cataractogenic
Pubmed Data : Exp Eye Res. 1990 Jan ;50(1):65-78. PMID: 2307197
Study Type : Review
Additional Links
Pharmacological Actions : Anticholesteremic Agents
Problem Substances : Lovastatin, Simvastatin, Statin Drugs
Adverse Pharmacological Actions : Cataractogenic

Cataractogenic Related Articles

Written by Serena Goldstein ND
The chemicals in feminine hygiene products have been linked to a host of issues, including cancers, inflammatory conditions, infections, and hormonal concerns
Written by Sayer Ji, Founder
As we age our eyes gradually cloud over, with unchecked cataracts the leading cause of blindness. Here are 4 simple things you can do to make sure your eyes stay youthful late into life
Written by Sinfully Wholesome
Medical errors kill enough people to fill four jumbo jets a week. Here are 7 Tips on Surviving Medical Industrial Complex.

Print Options

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2023, Journal Articles copyright of original owners, MeSH copyright NLM.